Sexuality and fertility in women with Addison's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages 4354-4360

  Erichsen, Martina Moter ^a,b   Husebye, Eystein S ^a,b   Michelsen, Trond M ^c,d,e   Dahl, Alv A ^c,f   Løvås, Kristian ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Section for Gastroenterology   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA ANDROSTANEDIOL; ANDROGEN; ANDROSTANEDIOL; PRASTERONE;

ADDISON DISEASE; AGE DISTRIBUTION; ANDROGEN BLOOD LEVEL; ARTICLE; BIRTH RATE; BLOOD DONOR; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; FERTILITY; HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SALPINGOOOPHORECTOMY; SEXUALITY; ADULT; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY RATE; PRIMARY OVARIAN INSUFFICIENCY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; VERY ELDERLY; YOUNG ADULT;

ADDISON DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; CASE-CONTROL STUDIES; FEMALE; FERTILITY; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY RATE; PRIMARY OVARIAN INSUFFICIENCY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUALITY; YOUNG ADULT;

EID: 77956563348     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0445     Document Type: Article

References (41)

1. Løvås K, Loge JH, Husebye ES 2002 Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56:581-588
2. Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VK 2008 Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 93:400-409
3. Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES 2009 Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882-4890
4. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
5. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK 2000 Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650-4656
6. Løvås K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebø BG, Myking OL, Kämpe O, Husebye ES 2003 Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88:1112-1118
7. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P 2003 Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 49:1381-1395
8. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J 2006 Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 99:182-188
9. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA 2000 Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682-688
10. Penotti M, Sironi L, Cannata L, Viganò P, Casini A, Gabrielli L, Vignali M 2001 Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries. Fertil Steril 76:235-240
11. Morales AJ, Nolan JJ, Nelson JC, Yen SS 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367
12. Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE 1999 The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84:3896-3902
13. Løvås K, Husebye ES 2003 Replacement therapy in Addison's disease. Expert Opin Pharmacother 4:2145-2149
14. van Thiel SW, Romijn JA, Pereira AM, Biermasz NR, Roelfsema F, van Hemert A, Ballieux B, Smit JW 2005 Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 90:3295-3303
15. Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A 2006 Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 91:1683-1690
16. Perheentupa J 2006 Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91:2843-2850
17. Thirlaway K, Fallowfield L, Cuzick J 1996 The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res 5:81-90
18. Vistad I, Fosså SD, Kristensen GB, Mykletun A, Dahl AA 2007 The sexual activity questionnaire: pychometric properties and normative data in a Norwegian population sample. J Womens Health (Larchmt) 16:139-148
19. Stead ML, Crocombe WD, Fallowfield LJ, Selby P, Perren TJ, Garry R, Brown JM 1999 Sexual activity questionnaires in clinical trials: acceptability to patients with gynaecological disorders. Br J Obstet Gynaecol 106:50-54
20. Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A 2003 Effect of raloxifene on sexual function in postmenopausal women. Climacteric 6:248-256
21. Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC 2004 Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 22:881-889
22. Fallowfield L, Fleissig A, Edwards R, West A, Powles TJ, Howell A, Cuzick J 2001 Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol 19:1885-1892
23. Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S, Husebye ES 2008 Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clin Immunol 129:163-169
24. Nakagawa S, Cuthill IC 2007 Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev 82:591-605
25. Cohen J 1988 Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Earlbaum
26. Burger HG 2002 Androgen production in women. Fertil Steril 77(Suppl 4):S3-S5
27. Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J 2008 Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol 110:1-9
28. van Rijn T 2009 A psychiatrist's view of response shift. J Clin Epidemiol 62:1191-1195
29. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG 2003 Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 79:1341-1352
30. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N 2006 Androgen therapy in women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 91:3697-3710
31. Davis SR, Davison SL, Donath S, Bell RJ 2005 Circulating androgen levels and self-reported sexual function in women. JAMA 294:91-96 (Pubitemid 41002843)
32. Hines M, Ahmed SF, Hughes IA 2003 Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav 32:93-101
33. Wisniewski AB, Migeon CJ 2002 Long-term perspectives for 46,XY patients affected by complete androgen insensitivity syndrome or congenital micropenis. Semin Reprod Med 20:297-304
34. Minto CL, Liao KL, Conway GS, Creighton SM 2003 Sexual function in women with complete androgen insensitivity syndrome. Fertil Steril 80:157-164
35. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F 2000 Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 97:4279-4284
36. Hackbert L, Heiman JR 2002 Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Womens Health Gend Based Med 11:155-162
37. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR 2005 Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62:154-162
38. Ambrosi B, Barbetta L, Morricone L 2003 Diagnosis and management of Addison's disease during pregnancy. J Endocrinol Invest 26:698-702
39. Heijmans M 1999 The role of patients' illness representations in coping and functioning with Addison's disease. Br J Health Psychol 4:137-149
40. Klee M, Groenvold M, Machin D 1997 Quality of life of Danish women: population-based norms of the EORTC QLQ-C30. Qual Life Res 6:27-34
41. Stigum H, Magnus P, Harris JR, Samuelsen SO, Bakketeig LS 1997 Frequency of sexual partner change in a Norwegian population. Data distribution and covariates. Am J Epidemiol 145:636-643